Alfon, Melfe .
HRN: 12-86-17 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/08/2023
CEFUROXIME 1.5GM (VIAL)
09/08/2023
09/09/2023
IV
1.5gm
Q8H X 3 Doses
Post CS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes